Company Revive Therapeutics Ltd Toronto S.E.
Equities
RVV
CA7615161030
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% |
|
+6.67% | -11.11% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 19-12-17 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 19-12-17 |
William Jackson
BRD | Director/Board Member | - | 13-12-31 |
Andrew Lindzon
BRD | Director/Board Member | 63 | 19-12-17 |
Director/Board Member | 50 | 19-12-17 | |
Joshua Herman
BRD | Director/Board Member | - | 19-12-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 418,564,269 | 412,444,735 ( 98.54 %) | 0 | 98.54 % |
Company contact information
Revive Therapeutics Ltd.
The Canadian Venture Building 82 Richmond Street East
M5C 1P1, Toronto
+888-901-0036
http://www.revivethera.com![address Revive Therapeutics Ltd(RVV)](https://cdn.zonebourse.com/static/address/18313352.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- RVV Stock
- RVV Stock
- Company Revive Therapeutics Ltd